| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 91261 |
DOTA-tris(acid)-amido-dPEG-bromoacetamide DOTA-酸性酰胺-离散聚乙二醇-溴乙酰胺 |
235 |
zcy |
2024-11-29 |
| 91262 |
降冰片烯二酸酐-马来酰亚胺基七异丁基POSS交替共聚物 P(NA-alt-MIPOSS) |
299 |
h |
2024-11-29 |
| 91263 |
环氧降冰片烷 EPO-NBE |
325 |
h |
2024-11-29 |
| 91264 |
NOTA-SPM 大环配体DOTA修饰SPM探针 |
148 |
zyl |
2024-11-29 |
| 91265 |
74389-69-8;C18-02:0 PC;血小板活化因子(C18) |
326 |
kx |
2024-11-29 |
| 91266 |
2-氨基金刚烷(2-NH2-Adam) |
211 |
h |
2024-11-29 |
| 91267 |
多肽修饰四氮杂环十二烷四乙酸(DOTA)的方法 |
283 |
zcy |
2024-11-29 |
| 91268 |
NH2-DOTA-GA , 有氨基的DOTA衍生物 |
193 |
wyh |
2024-11-29 |
| 91269 |
4-(1-金刚烷基)-1,3-二苯酚(ADRL) |
197 |
h |
2024-11-29 |
| 91270 |
N,N,N-三甲基-1-金刚烷基季铵盐 |
310 |
h |
2024-11-29 |
| 91271 |
NH2-DOTA-GA ,氨基-大环配体-甘草次酸 ,1639843-65-4 |
157 |
wyh |
2024-11-29 |
| 91272 |
NOTA-RGD-ATWLPPR NOTA-NHS活化酯偶联双靶点分子探针RGD-ATWLPPR |
180 |
zyl |
2024-11-29 |
| 91273 |
1,3-二(4-羟苯基)金刚烷(DPAD) |
236 |
h |
2024-11-29 |
| 91274 |
CAS:1027160-33-3 FITC-PEG2-TATE |
252 |
zcy |
2024-11-29 |
| 91275 |
97802-55-6;C18(Plasm) LPC; |
233 |
kx |
2024-11-29 |
| 91276 |
250612-06-7 , DOTA-E[CYCLO(RGDFK)]2探针多肽 |
161 |
wyh |
2024-11-29 |
| 91277 |
NOTA/NODAGA NOTA偶联NODAGA环状多肽 |
251 |
zyl |
2024-11-29 |
| 91278 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, α10-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester, (α1S)- 定制 |
171 |
zcy |
2024-11-29 |
| 91279 |
DOTA-NHS DOTA-N-羟基琥珀酰亚胺酯 |
344 |
zcy |
2024-11-29 |
| 91280 |
NOTA-yG5-RGD NOTA修饰小分子环肽cyclo偶联c(RGDyK) |
150 |
zyl |
2024-11-29 |
| 91281 |
DOTA-E[cyclo(RGDfK)2] |
256 |
wyh |
2024-11-29 |
| 91282 |
CAS:170908-81-3 DOTA-活性酯 |
357 |
zcy |
2024-11-29 |
| 91283 |
C18-PEG12-COOH的分子结构、优势 |
227 |
kx |
2024-11-29 |
| 91284 |
钆特酸 72573-82-1 Gd-DOTA |
261 |
wyh |
2024-11-29 |
| 91285 |
2,2,4,4-四硝基金刚烷 |
171 |
h |
2024-11-29 |
| 91286 |
G2-NOTA(Mn2+)-PEG-RGD NOTA功能化低代树状大分子纳米材料 |
218 |
zyl |
2024-11-29 |
| 91287 |
N-[[4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基]乙酰基]-D-苯丙氨酰基-L-半胱氨酰基-L-酪氨酰基-D-色氨酰基-L-赖氨酰基-L-苏氨酰基-L-半胱氨酰基-L-苏氨酸, 环(2→7)-二硫化物 |
330 |
zcy |
2024-11-29 |
| 91288 |
金刚烷-1,3,5,7-四对苯三聚氰胺磺酸盐 |
263 |
h |
2024-11-29 |
| 91289 |
DOTA-GA(tBu)4 ;DOTAGA-tetra (t-Bu ester) |
218 |
wyh |
2024-11-29 |
| 91290 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 DOTA-tris(acid)-amido-dPEG (R)11-Maleimide |
226 |
zcy |
2024-11-29 |
| 91291 |
NOTA-PEG4-cRGD2 NOTA-四聚乙二醇-cRGD2环肽 |
202 |
zyl |
2024-11-29 |
| 91292 |
DOTAGlu-C(AGADPL)2 ; 250612-06-7 |
150 |
wyh |
2024-11-29 |
| 91293 |
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- 定制 |
204 |
zcy |
2024-11-29 |
| 91294 |
NOTA-octreotide NOTA-奥曲肽 大环配体NOTA偶联奥曲肽 |
209 |
zyl |
2024-11-29 |
| 91295 |
NOTA-Exendin4 NOTA-艾塞那肽 |
212 |
zyl |
2024-11-29 |
| 91296 |
CAS:1262311-97-6 大环化合物 |
230 |
zcy |
2024-11-29 |
| 91297 |
荧光增强型四嗪生物正交荧光探针 |
354 |
WYQ |
2024-11-29 |
| 91298 |
靶向对比剂 CREKA-(Gd-DOTA)4 |
210 |
wyh |
2024-11-29 |
| 91299 |
NOTA-PEG6-TATE 大环NOTA-六聚乙二醇-奥曲肽 |
163 |
zyl |
2024-11-29 |
| 91300 |
四嗪共轭修饰萘环(Tz-Naphthalene) |
272 |
WYQ |
2024-11-29 |
| 91301 |
C18-PEGn-OH的分子结构、特性与应用 |
232 |
kx |
2024-11-29 |
| 91302 |
四嗪标记探针TNO是一种基于四嗪结构的探针分子 |
217 |
WYQ |
2024-11-29 |
| 91303 |
NOTA-多肽-PEG11-Tz NOTA-多肽-十一聚乙二醇-四嗪 |
193 |
zyl |
2024-11-29 |
| 91304 |
3-氨基-6-三氟甲基-1,2,4,5-四嗪-1,5-二氧化物(Ⅷ) |
202 |
WYQ |
2024-11-29 |
| 91305 |
NH2-DOTA-GA ;氨基-大环配体-甘草次酸 ;CAS1639843-65-4 |
191 |
wyh |
2024-11-29 |